Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BIT/1BMRN stock hub

BIT/1BMRN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/1BMRNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.9B

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/1BMRN

In the news

Latest news · BIT/1BMRN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.3

P25 n/aP50 n/aP75 n/a

Trailing P/E38.1

P25 n/aP50 n/aP75 n/a

ROE4.5

P25 n/aP50 n/aP75 n/a

ROIC7.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/1BMRN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

USD

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	IT
Employees	3,221
Employees Change	-361%
Employees Change Percent	-10.61
Enterprise value	EUR 8.2B
Exchange	Borsa Italiana
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 8.9B
Price	EUR 45.76
Price currency	EUR
Rev Per Employee	873,039.64x
Sic	2836
Symbol	bit/1BMRN
Website	https://www.biomarin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.63%
EV Earnings	35.23x
EV/EBIT	17.11x
EV/EBITDA	15.06x
EV/FCF	12.34x
EV/Sales	2.98x
FCF yield	7.49%
Forward P/E	9.29x
P/B ratio	1.65x
P/E ratio	38.08x
P/S ratio	3.16x
PE Ratio3 Y	60.93x
PE Ratio5 Y	150.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.42%
EBITDA Margin	19.47%
FCF margin	23.66%
Gross margin	51.16%
Gross Profit	EUR 1.4B
Gross Profit Growth	0.97%
Gross Profit Growth Q	-9.76%
Gross Profit Growth3 Y	17.97%
Gross Profit Growth5 Y	19.64%
Net Income	EUR 233.1M
Net Income Growth	-48.7%
Net Income Growth Q	-43.17%
Net Income Growth3 Y	55.4%
Net Income Growth5 Y	-19.5%
Pretax Margin	11.89%
Profit Margin	8.29%
Profit Per Employee	EUR 72,363
ROA	4.49
Roa5y	2.28
ROCE	7.24
ROE	4.48
Roe5y	3.83
ROIC	7.43
Roic5y	3.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-12.75%
Cagr3y	-19.43%
Cagr5y	-6.7%
EPS Growth	-48.33
EPS Growth Q	-43.42
EPS Growth3 Y	55.68
EPS Growth5 Y	-19.74
FCF Growth	22.89%
FCF Growth Q	26.71%
FCF Growth3 Y	192.02%
FCF Growth5 Y	46.21%
OCF Growth	24.85%
OCF Growth Q	26.52%
OCF Growth3 Y	81.01%
OCF Growth5 Y	32.5%
Revenue Growth	9.9x
Revenue Growth Q	2.83x
Revenue Growth3 Y	14.27x
Revenue Growth5 Y	11.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.41
Assets	EUR 7.5B
Cash	EUR 1.9B
Current Assets	EUR 3.9B
Current Liabilities	EUR 672.6M
Debt	EUR 1.2B
Debt EBITDA	EUR 2.24
Debt Equity	EUR 0.23
Debt FCF	EUR 1.88
Equity	EUR 5.4B
Interest Coverage	24.56
Liabilities	EUR 2.1B
Long Term Assets	EUR 3.5B
Long Term Liabilities	EUR 1.4B
Net Cash	EUR 679M
Net Cash By Market Cap	EUR 7.65
Net Cash Growth	18.17%
Net Debt EBITDA	EUR -1.24
Net Debt Equity	EUR -0.13
Net Debt FCF	EUR -1.02
Tangible Book Value	EUR 5B
Tangible Book Value Per Share	EUR 26.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.81
Inventory Turnover	1.24
Net Working Capital	EUR 1.4B
Quick ratio	3.94
Working Capital	EUR 3.3B
Working Capital Turnover	EUR 0.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-12.74%
200-day SMA	48.21
3Y total return	-47.7%
50-day SMA	48.35
50-day SMA vs 200-day SMA	50over200
5Y total return	-29.3%
All Time High	114.8
All Time High Change	-60.15%
All Time High Date	2020-07-07
All Time Low	43.05
All Time Low Change	6.3%
All Time Low Date	2025-06-16
ATR	0.52
Ch YTD	-9.24
High52	55.2
High52 Date	2026-02-23
High52ch	-17.1%
Low52	43.05
Low52 Date	2025-06-16
Low52ch	6.3%
Ma50ch	-5.36%
Price vs 200-day SMA	-5.08%
RSI	40.41
RSI Monthly	37.9
RSI Weekly	42.57
Sharpe ratio	-0.41x
Sortino ratio	-0.51
Total Return	-0.86%
Tr YTD	-9.24
Tr1m	-4.81%
Tr1w	-1.29%
Tr3m	-6.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 489.8M
Operating Income Growth	-21.1
Operating Income Growth Q	-38.52
Operating Income Growth3 Y	78.02
Operating margin	17.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	192,153,823%
Net Borrowing	720,767,700
Shares Insiders	0.49%
Shares Institutions	97.14%
Shares Qo Q	2.83%
Shares Yo Y	0.86%
Short Ratio	4.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 502.9M
Average Volume	29x
Bv Per Share	27.88
CAPEX	EUR -93M
Ch1m	-4.81
Ch1w	-1.29
Ch1y	-12.74
Ch3m	-6.97
Ch3y	-47.7
Ch5y	-29.3
Ch6m	4.12
Change	-0.09%
Close	45.8
Depreciation Amortization	56,388,625
Earnings Date	2026-04-24
EBIT	EUR 489.8M
EBITDA	EUR 547.5M
EPS	EUR 1.21
F Score	5
FCF	EUR 665.3M
FCF EV Yield	8.1x
Financing CF	702,124,450
Fiscal Year End	December
Founded	1,996
Goodwill	166,369,296.4
Graham Number	27.40178
Graham Upside	-40.12
Income Tax	EUR 101.3M
Investing CF	294,469,165
Is Primary Listing	0
Last Earnings Date	2026-02-23
Last Report Date	2026-03-31
Lynch Fair Value	EUR 6.01
Lynch Upside	-86.87
Ma150	47.99
Ma150ch	-4.64%
Ma20	46.24
Ma20ch	-1.03%
Net CF	1,755,096,034
P FCF Ratio	13.34
P OCF Ratio	11.71
Ppne	812,407,801.3
Price Date	2026-05-08
Price EBITDA	EUR 16.21
Ptbv Ratio	1.76
Relative Volume	0.79x
Revenue	2,812,060,667x
SBC By Revenue	5.77x
Share Based Comp	162,329,939
Tax By Revenue	3.6x
Tax Rate	30.3%
Tr6m	4.12%
Z Score	3.94

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BIT/1BMRN pay a dividend?

Capital-return profile for this ticker.

Performance

BIT/1BMRN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/1BMRN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+97.1%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BIT/1BMRN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.4

Neutral momentum band

Price vs 200-day MA

-5.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/1BMRN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1BMRN stock rating?

bit/1BMRN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1BMRN analysis?

The full report lives at /stocks/bit/1BMRN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1BMRN?

The latest report frames bit/1BMRN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1BMRN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.